| UROGENE Patent applications |
| Patent application number | Title | Published |
|---|
| 20100063102 | TREATMENT OF FAECAL INCONTINENCE - Use of a compound corresponding to formula (I) in which R represents hydrogen or a group chosen from alkyl, alkylene, alkylidyne, cycloalkyl, cycloalkylene, cycloalkylidyne and —CONH2 groups, and the —COR′ and —COOR′ groups, in which R′ is chosen from alkyl, alkylene, alkylidyne, cycloalkyl, cycloalkylene and cycloalkylidyne groups, it being possible for said groups R and/or R′ to be substituted and/or interrupted with -0-, —COO—, —OCO—, —NHCO— or —CONH— functions, or a pharmaceutically acceptable salt of said compound, for obtaining a medicament for use in the treatment of faecal incontinence. | 03-11-2010 |
| 20090048304 | Crystal Form of Besipirdine Chlorhydrate, Process Preparation and Use Thereof - Crystal form of besipirdine chlorhydrate (Form I) corresponding to the Formula (A) below: the aforementioned form being characterized at least by one of the following physico-chemical properties: a) In FTIR, it displays at least the following absorption bands of the infrared spectrum: 778, 1198, 1121, but not the following absorption bands of the infrared spectrum: 3395, 1583, 732, the aforementioned bands being expressed in cm | 02-19-2009 |
| 20090036496 | Treatment of Stress Urinary Incontinence and Mixed Urinary Incontinence - Use of a compound corresponding to formula (I): in which R represents hydrogen or a group chosen from alkyl, alkylene, alkylidyne, cycloalkyl, cycloalkylene, cycloalkylidyne and —CONH | 02-05-2009 |
| 20080293774 | Treatment of the Symptoms of Bladder Irritation - Use of a compound corresponding to formula (I), for obtaining a medicinal product for use in the treatment of the symptoms of bladder irritation. | 11-27-2008 |
